News and Trends 10 Nov 2022 Looking for cancer clues? Copper may open new drug treatment doors …to breast cancer cells being able to move and form metastases. Overall, the findings in the new study mean that copper and copper-binding proteins could be targets for future cancer… November 10, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Opinion 2 Feb 2023 How digital biomarker assays can harness the power of deep learning from clinical trials to the clinic …expressing breast cancers is a great example. Historically, about 15% of breast cancer patients were believed to be HER2-positive.1 Recent studies revealed however that there is a subset of patients… February 2, 2023 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 21 Nov 2019 €37.4M Invested in Azeria Therapeutics’ Cancer Treatment Program …developed by Azeria with have a completely different mode of action to those already used in breast cancer. Myatt explained: “The treatment paradigm in estrogen receptor-positive breast cancer is primarily… November 21, 2019 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 16 Sep 2024 Vironexis’ AAV vector approach: The next frontier in cancer immunology? …are using it for cancer, and not only ALL with VNX-101, Vironexis’ most advanced candidate. “Our second product in the pipeline (VNX-202) is treating HER2+ breast cancer and gastric cancer…. September 16, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2025 First-ever RIPTAC enters clinic: all you need to know about this new cancer approach …foundation that has resulted in our pipeline of RIPTAC therapeutics for major cancers.” Can RIPTACs tackle unmet needs of patients with prostate cancer? This is a step forward in prostate… March 24, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 AI model study may lead to identifying skin cancer from blood test …“Our AI model is agile and adaptable, making it possible to calculate the number of cancer-sensing defensive cells also in the case of other cancers, including breast cancer, lung cancer… October 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 6 Oct 2023 Will the U.S. Cancer Moonshot program land its target to halve cancer death rates? …First Cancer Moonshot grant awarded to Yale’s cancer vaccine project As the program strives to tackle the rising cancer cases, the ARPA-H – which was born out of the Defense… October 6, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Opinion 1 Nov 2023 Could this be the start of a new era for PI3K drugs? …Phase 1/ 2 Mut-Sel PI3Ka inhibitor Breast cancer/solid tumors Eli Lilly/Loxo LOXO-783 Phase 1 PI3Ka inhibitor Cancer AstraZeneca Capivasertib Registration AKT inhibitor Breast cancer, also phase 3 in prostate cancer… November 1, 2023 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 9 May 2023 5 cancers that immunotherapy can cure …various different types of immunotherapy for this type of cancer. Immunotherapy for ovarian cancer According to the American Cancer Society (ACS), ovarian cancer is the fifth leading cause of cancer… May 9, 2023 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 21 Dec 2022 Artificial DNA can kill cancer …human cervical cancer– and breast cancer-derived cells, and against malignant melanoma cells from mice. The team created a pair of chemically synthesized, hairpin-shaped, cancer-killing DNA. When the DNA pairs were… December 21, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 2 May 2018 Combining Liquid Biopsy and Artificial Intelligence to Outrun Cancer …treating cancer is its ability to rapidly mutate. “Cancer evolves. Your tumor today is not going to be your tumor in three months,” says John Cassidy, CEO of Cambridge Cancer… May 2, 2018 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Mar 2024 Fourteen biotech companies with market caps exceeding $100 billion …approval in 2023 of Enhertu for HER2-low metastatic breast cancer represents a significant advancement in cancer treatment, marking it as the first HER2-directed therapy for this patient group. More recently,… March 5, 2024 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email